Dr. Kalika P. Sarma, MD

Dr. Sarma practices at Carle Foundation Hospital in Urbana, Illinois, part of The Carle Foundation.

Dr. Sarma's NPI, 1679672398, was assigned on September 21, 2006. Dr. Sarma holds Illinois license 036112860.

Dr. Sarma's primary practice is Carle Foundation Hospital, at 611 West Park Street, Urbana, IL 61801 in Champaign County. The practice phone is (217) 383-3311.

Dr. Sarma's primary practice is Carle Foundation Hospital in Urbana, Illinois, part of The Carle Foundation. The medical group on file is Carle Physician Group. Dmand AI also links Dr. Sarma to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sarma practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Sarma's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Sarma is licensed in Illinois.

CMS data shows 771 Medicare services from Dr. Sarma across 14 procedure codes in 2024, for 164 Medicare patients. Medicare paid $59,362 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 164 Medicare patients who saw Dr. Sarma in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sarma's median patient age at 74, with 58% women.

In 2024, Dr. Sarma wrote 82 Medicare Part D claims for 43 patients. 63% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $244 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.

Dr. Sarma accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Sarma, published from 2016 to 2021. 2018 was the busiest year, with 2. The most frequent topics are Head and Neck Neoplasms, Cancer Survivors and Nutritional Status. Dr. Sarma's most frequent co-authors are Tracy E. Alpert, MD, Beatrice F. Bloom, MD and Albert S. Denittis, MD.

Dmand AI links Dr. Sarma to 7 clinical trials, 4 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Breast Neoplasms, Brain Neoplasms and Cognitive Dysfunction. NRG Oncology sponsors the most, 4.